NCT02397668 - CorMatrix Cor TRICUSPID ECM Valve Replacement Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2026

Conditions

Tricuspid Valve Disease

Interventions

DEVICE

CorMatrix Cor TRICUSPID ECM Valve

CorMatrix Cor TRICUSPID ECM Valve to replace a diseased tricuspid valve, including tricuspid valve disease secondary to congenital heart disease.

Trial Locations (4)

RECRUITING

Medstar, Baltimore

RECRUITING

Springhill Memorial Hospital, Mobile

RECRUITING

Cincinnati Children's Hospital, Cincinnati

RECRUITING

St Francis Hospital, Indianapolis